A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response

INTRODUCTION: Thrombopoietin (TPO) being the major regulator of megakaryopoiesis is expected to show a compensatory increase in immune thrombocytopenia (ITP), however, it is not so observed. This study was undertaken to measure TPO levels in ITP and assesses its association with platelet count, mega...

Full description

Bibliographic Details
Main Authors: Gurleen Oberoi, Mili Jain, Shankar Madhav Natu, Rashmi Kushwaha, Anil Kumar Tripathi, Ashutosh Kumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Asian Journal of Transfusion Science
Subjects:
Online Access:http://www.ajts.org/article.asp?issn=0973-6247;year=2022;volume=16;issue=1;spage=95;epage=98;aulast=
_version_ 1818503543080878080
author Gurleen Oberoi
Mili Jain
Shankar Madhav Natu
Rashmi Kushwaha
Anil Kumar Tripathi
Ashutosh Kumar
author_facet Gurleen Oberoi
Mili Jain
Shankar Madhav Natu
Rashmi Kushwaha
Anil Kumar Tripathi
Ashutosh Kumar
author_sort Gurleen Oberoi
collection DOAJ
description INTRODUCTION: Thrombopoietin (TPO) being the major regulator of megakaryopoiesis is expected to show a compensatory increase in immune thrombocytopenia (ITP), however, it is not so observed. This study was undertaken to measure TPO levels in ITP and assesses its association with platelet count, megakaryocytes, and response to steroid therapy. MATERIALS AND METHODS: A total of 41 cases of ITP and twenty controls with normal platelet count were enrolled in this prospective study. Complete blood count, bone marrow examination, and ELISA for serum TPO were measured. Response to steroid therapy was evaluated for thirty cases. RESULTS: The TPO levels were increased in 80.5% of patients in comparison to the controls. The degree of rise, however, was variable. On analyzing low, normal, and high TPO levels with reference to platelet and megakaryocyte count no statistically significant difference was observed. Raised TPO levels were seen with significant lowering of functional megakaryocytes. The mean TPO levels in nonresponders were higher than responders but highly variable and statistically nonsignificant. CONCLUSION: Quantitative alterations in TPO are in a way regulated by qualitative efficacy of megakaryocytes rather than platelet or megakaryocyte count. Nonresponders with markedly increased TPO levels (due to qualitative megakaryocyte injury) are less likely to respond to TPO receptor agonist.
first_indexed 2024-12-10T21:25:22Z
format Article
id doaj.art-f56fe435ed844ae49efcc1586f4e45c5
institution Directory Open Access Journal
issn 0973-6247
1998-3565
language English
last_indexed 2024-12-10T21:25:22Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Transfusion Science
spelling doaj.art-f56fe435ed844ae49efcc1586f4e45c52022-12-22T01:33:01ZengWolters Kluwer Medknow PublicationsAsian Journal of Transfusion Science0973-62471998-35652022-01-01161959810.4103/ajts.AJTS_65_17A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment responseGurleen OberoiMili JainShankar Madhav NatuRashmi KushwahaAnil Kumar TripathiAshutosh KumarINTRODUCTION: Thrombopoietin (TPO) being the major regulator of megakaryopoiesis is expected to show a compensatory increase in immune thrombocytopenia (ITP), however, it is not so observed. This study was undertaken to measure TPO levels in ITP and assesses its association with platelet count, megakaryocytes, and response to steroid therapy. MATERIALS AND METHODS: A total of 41 cases of ITP and twenty controls with normal platelet count were enrolled in this prospective study. Complete blood count, bone marrow examination, and ELISA for serum TPO were measured. Response to steroid therapy was evaluated for thirty cases. RESULTS: The TPO levels were increased in 80.5% of patients in comparison to the controls. The degree of rise, however, was variable. On analyzing low, normal, and high TPO levels with reference to platelet and megakaryocyte count no statistically significant difference was observed. Raised TPO levels were seen with significant lowering of functional megakaryocytes. The mean TPO levels in nonresponders were higher than responders but highly variable and statistically nonsignificant. CONCLUSION: Quantitative alterations in TPO are in a way regulated by qualitative efficacy of megakaryocytes rather than platelet or megakaryocyte count. Nonresponders with markedly increased TPO levels (due to qualitative megakaryocyte injury) are less likely to respond to TPO receptor agonist.http://www.ajts.org/article.asp?issn=0973-6247;year=2022;volume=16;issue=1;spage=95;epage=98;aulast=immune thrombocytopeniamegakaryocytethrombocytopeniathrombopoietin
spellingShingle Gurleen Oberoi
Mili Jain
Shankar Madhav Natu
Rashmi Kushwaha
Anil Kumar Tripathi
Ashutosh Kumar
A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
Asian Journal of Transfusion Science
immune thrombocytopenia
megakaryocyte
thrombocytopenia
thrombopoietin
title A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
title_full A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
title_fullStr A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
title_full_unstemmed A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
title_short A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
title_sort cross sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count megakaryocytes and treatment response
topic immune thrombocytopenia
megakaryocyte
thrombocytopenia
thrombopoietin
url http://www.ajts.org/article.asp?issn=0973-6247;year=2022;volume=16;issue=1;spage=95;epage=98;aulast=
work_keys_str_mv AT gurleenoberoi acrosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse
AT milijain acrosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse
AT shankarmadhavnatu acrosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse
AT rashmikushwaha acrosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse
AT anilkumartripathi acrosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse
AT ashutoshkumar acrosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse
AT gurleenoberoi crosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse
AT milijain crosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse
AT shankarmadhavnatu crosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse
AT rashmikushwaha crosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse
AT anilkumartripathi crosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse
AT ashutoshkumar crosssectionalstudyonthrombopoietinlevelsinimmunethrombocytopeniaanditscorrelationwithplateletcountmegakaryocytesandtreatmentresponse